陇神戎发：取得血液透析浓缩液（干粉）产品生产和上市销售资质

Core Viewpoint - The company has obtained a medical device production license for its blood dialysis concentrate (dry powder) product, enabling production and market sales [1] Group 1 - The license was issued by the Gansu Provincial Drug Administration on February 5, 2026 [1] - The blood dialysis concentrate (dry powder) is used for blood dialysis treatment in acute and chronic renal failure and has been widely applied in clinical settings [1]